Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT04989309

Left and Right Hemisphere Contributions to Speech Perception

Left and right temporal brain areas are thought to contribute to speech perception, but the division of labor between left and right hemisphere regions is still unclear. Here we use transcranial magnetic stimulation (TMS) to stimulate left and right temporal foci and a vertex control site to temporarily disrupt activation at the stimulation site, using a "virtual lesion" approach to test the effect of stimulation site on a series of speech perception tasks.

This portion of the project is basic research. However, since TMS is viewed as an intervention, studies involving TMS in this grant are considered clinical trials.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Connecticut

Storrs, Connecticut, 06268, United States

About this study

This study uses TMS to temporarily disrupt neural activity in the left and right temporal cortex and examine the effect of this disruption on speech perception tasks. Vertex stimulation is included as a control condition against which left and right superior temporal stimulation effects are compared. Adult participants first undergo structural MRI and a speech localizer using functional MRI to identify speech-sensitive voxels in the left and right temporal cortex. These regions are set by-participant as the foci for stimulation. Stimulation site is blocked, and typically distributed across sessions. 10 Hz pulse trains of 2.5 sec each are delivered to the stimulation site, with an auditory stimulus arriving either immediately after the last pulse (Exps 2 and 6) or, for longer sentence level stimuli (Exp 3), during the pulse train. Behavioral measures include accuracy and reaction times to rate phonetic stimuli (Exp 2), detect the presence of a probe word in the preceding sentence (Exp 3), or categorize stimuli by phonetic contrast and talker (Exp 6).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Monolingual native speaker of English
  • No history of neurological impairments or disease
  • Free of speech and language disorders (per self-report, and confirmed by short language battery described by Fidler, Vance, & Plante, 2011)
  • Pure-tone thresholds of 30 decibels or better in both ears (no worse than mild hearing loss), with no more than 15 dB between-ear difference.
  • Right-handed, as confirmed by Oldfield Handedness Inventory

Exclusion criteria

  • Any condition where TMS would be contraindicated according to the most recent guidelines, including, but not limited to:
  • History of seizure or epilepsy
  • Metal in the skull
  • Use of legal or illicit drugs that can potentially reduce the threshold for seizure. As examples, we list some exclusionary drugs in each of the following categories. This is not an exhaustive list of the exclusionary drugs. We consult with faculty in the University of Connecticut College of Pharmacy to check for seizure risk with other drugs that participants report.
  • Antidepressants including Imipramine, amitriptyline, sertraline, venlafaxine, buproprion
  • Antipsychotics including Chlorpromazine, clozapine, haloperidol, aripiprazole
  • Antivirals including foscarnet, ganciclovir
  • Antiparasitics including chloroquine, mefloquine (antiparasitics)
  • Antibiotics including penicillin, ampicillin
  • Immunosuppressants including cyclosporin
  • Anticholinergenics
  • Antihistimines (including over-the-counter drugs like Claritin & Benadryl)
  • Sympathomimetics (including Sudafed, Ritalin).
  • Illegal drugs such as methamphetamines, cocaine, MDMA, ketamine.
  • Diagnosis of a psychiatric disorder (per self-report)
  • Pregnancy

Treatment and study plan

Transcranial Magnetic Stimulation

Device

TMS will be delivered in 10 Hz pulses for 2.5 seconds, with behavioral measures of speech perception and object categorization immediately following each pulse. TMS at this schedule is thought to temporarily disrupt activity at the stimulation site.

Primary outcomes

  1. Categorization accuracy

    Time frame: Immediately following the stimulation pulses (within one second of the final pulse).

    Participants categorize items which vary along a perceptual continuum. Steepness of the categorization curve is extracted to estimate categorization accuracy.

  2. Two-alternative forced choice accuracy

    Time frame: Immediately following the stimulation pulses (within one second of the final pulse).

    Participants are given two options and asked to indicate which item they heard in the previous signal. Accuracy in making this decision is a primary outcome measure.

  3. Two-alternative forced choice reaction time

    Time frame: Immediately following the stimulation pulses (within one second of the final pulse).

    Participants are given two options and asked to indicate which item they heard in the previous signal. Reaction time to make this decision is a primary outcome measure.

Sponsors and collaborators

Lead sponsor

University of Connecticut

Other

Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

Registry information

Official study title

The Role of Frontal and Temporal Brain Areas in the Perception of Phonetic Category Structure

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Aug 4, 2021
Registry last updated
Jun 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.